Medical products: iohexol, dexamethasone and sodium chloride
Prozorro projected procurement value; VAT excluded.
Prozorro public procurement API
Overview
The State Institution “O.S. Kolomiychenko Institute of Otolaryngology” of Ukraine’s National Academy of Medical Sciences sought three medicines: 50 units of iohexol injection solution (350 mg/ml, 100 ml); 30 units of dexamethasone injection solution (4 mg/ml); and 20 units of sodium chloride infusion solution (9 mg/ml, 100 ml). The current Prozorro API record gives a projected value of UAH 33,000 excluding VAT and lowest-cost evaluation. It marks the procedure unsuccessful as of 13 October 2026; no award or contract is recorded and no reason is supplied. The public notice includes active item specifications, sanctions and goods-origin restrictions, and a prior-contract reliability condition. The API states the offer deadline as 13 October 2026 at 08:00 Ukraine time (UTC+03:00), equal to 05:00 UTC in the available notice information.
Information based on the public notice
Ask about this tender
What the buyer needs
Three medicine items are listed in the current main Prozorro API record, with quantities, classifications and active item-level technical criteria. The structured API description field is empty; the public page returned only a JavaScript shell.
- An active sanctions criterion excludes participants or covered beneficial owners subject to a Ukrainian public-procurement ban and specified Russian, Belarusian or Iranian persons/entities; it also covers Ukrainian entities with at least 10% ownership by them, subject to the stated ARMA exception. Offered goods may not originate in those countries.
- For a same-buyer contract terminated early for supplier non-performance, with fines and/or damages imposed within the preceding three years and confirmed by a court decision, the buyer may reject the economically advantageous offer. A supplier with outstanding obligations may show reliability by paying or undertaking to pay obligations and damages.
- The main notice has active item-level specifications for all three medicines; these are summarized in the localized facts.
Tender details
- Buyer
- ДЕРЖАВНА УСТАНОВА "ІНСТИТУТ ОТОЛАРИНГОЛОГІЇ ІМ. ПРОФ. О.С. КОЛОМІЙЧЕНКА НАЦІОНАЛЬНОЇ АКАДЕМІЇ МЕДИЧНИХ НАУК УКРАЇНИ"
- Country
Ukraine
- Procedure
- priceQuotation
- Classification
- CPV 33690000-3
- Notice reference
- UA-2026-10-08-013213-a
- 1. Iohexol injection solution, 350 mg/ml, 100 ml - 50 units
- 50 units. INN Iohexol; DK021 code 33690000-3. Active item criteria specify volume 100 (the title identifies ml), dose 350 mg/ml, injection solution, ATC V08AB02 and INN Iohexol.
- 2. Dexamethasone injection solution, 4 mg/ml - 30 units
- 30 units. INN Dexamethasone; DK021 code 33640000-8. Active item criteria specify injection solution, ATC H02AB02, dose 4 mg/ml and ampoule packaging. A separate criterion states volume “1” without a unit; its unit is not specified in the API.
- 3. Sodium chloride infusion solution, 9 mg/ml, 100 ml - 20 units
- 20 units. INN Sodium chloride; DK021 code 33690000-3. Active item criteria specify infusion solution, ATC B05XA03, dose 9 mg/ml, volume 100 ml, packaging as vial, bottle or container, and at least one unit per package.
- Procurement value and evaluation
- The current API record states a projected value of UAH 33,000, excluding VAT, and lowest-cost evaluation. This is not an award amount.
- Procedure outcome
- The current API status is unsuccessful, last modified 13 October 2026 at 08:00:04 UTC+03:00. No award or contract objects are present, and the API does not state the reason.
- Sanctions and goods-origin conditions
- The active main-notice requirements bar a participant, beneficial owner or relevant member/shareholder subject to a public-procurement ban under Ukraine’s sanctions law. They also exclude specified Russian, Belarusian or Iranian persons/entities and Ukrainian entities with 10% or greater ownership by those persons/entities, except assets transferred to ARMA management; offered goods may not originate in Russia, Belarus or Iran.
- Previous-contract condition
- For a contract with this same buyer terminated early due to supplier non-performance, with fines and/or damages imposed within the prior three years and confirmed by a court decision, the buyer may reject the economically most advantageous offer. A supplier with outstanding obligations may demonstrate reliability by paying or undertaking to pay the obligations and damages.
What to check in the tender documents
- The current exact API record marks the procedure unsuccessful but states no reason; it contains no award or contract. The dexamethasone volume criterion is “1” without a unit. Separately linked procurement documents were not accessed.
Original notice
Read the original description
Йогексол, розчин для ін'єкцій, 350 мг/мл, по 100 мл; Дексаметазон,розчин для ін'єкцій 4мг/мл; Натрію хлорид, розчин для інфузій, 9 мг/мл 100 мл
Official source: Prozorro public procurement API ↗
Notice updates
October 15, 2026 · Version 2
Deadline information updated · Summary and analysis updated · Tender facts updated · Original notice updated · Deadline updated · Location updated · Source updated · Source notice details updated · Source references updated · Status changed
Йогексол, розчин для ін'єкцій, 350 мг/мл, по 100 мл; Дексаметазон,розчин для ін'єкцій 4мг/мл; Натрію хлорид, розчин для інфузій, 9 мг/мл 100 мл
October 12, 2026 · Version 1
Published
Йогексол, розчин для ін'єкцій, 350 мг/мл, по 100 мл; Дексаметазон,розчин для ін'єкцій 4мг/мл; Натрію хлорид, розчин для інфузій, 9 мг/мл 100 мл
Йогексол, розчин для ін'єкцій, 350 мг/мл, по 100 мл; Дексаметазон,розчин для ін'єкцій 4мг/мл; Натрію хлорид, розчин для інфузій, 9 мг/мл 100 мл
https://prozorro.gov.ua/tender/UA-2026-10-08-013213-a
Source retrieved: 2026-10-15T23:44:30.782435Z